“Efficacy of Oral DFD-29, a Low-Dose Minocycline Formulation, in Patients in Germany and Patients in the US: An Analysis of Two Phase 3 Trials”, J of Skin, vol. 10, no. 2, p. s765, Mar. 2026, doi: 10.25251/kf0b7204.